Related Experiment Videos
Quantifying and comparing the accuracy of binary biomarkers when predicting a failure time outcome
Chaya S Moskowitz1, Margaret S Pepe
1Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 307 East 63rd Street, 3rd Floor, New York, NY 10021, USA. moskowxc1@mskcc.org
Statistics in Medicine
|May 4, 2004
Summary
This study introduces extended predictive values to measure biomarker accuracy for survival data. These new metrics allow for rigorous comparison of biomarker predictive performance in survival analysis.
Area of Science:
- Biostatistics
- Survival Analysis
- Biomarker Validation
Background:
- Traditional predictive values assess binary outcomes, lacking standard methods for survival data.
- Accurate prediction of failure times is crucial in many medical and biological fields.
- Existing methods for evaluating biomarker accuracy in survival analysis are limited.
Purpose of the Study:
- To propose and validate extended predictive values for quantifying biomarker accuracy with censored survival data.
- To develop methods for rigorously comparing the predictive accuracy of multiple biomarkers.
- To provide a statistical framework for estimating and testing differences in biomarker predictive accuracy.
Main Methods:
- Extension of traditional positive and negative predictive values to handle censored survival data.
- Development of a marginal regression framework for estimating predictive accuracy.
- Statistical methods for comparing and testing the significance of differences in predictive accuracy between biomarkers.
Main Results:
- The proposed extended predictive values provide a standardized approach for assessing biomarker accuracy in survival analysis.
- The marginal regression framework allows for reliable estimation of predictive accuracy differences.
- Statistical tests enable rigorous comparison of biomarker performance.
Conclusions:
- The extended predictive values offer a robust and interpretable method for evaluating biomarkers predicting failure times.
- This framework facilitates more accurate biomarker selection and validation in survival studies.
- The proposed methods enhance the quantitative assessment of predictive accuracy in censored survival data.